1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: IVF Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. IVF Services Market, by Cycle Type
8.1.1 Fresh IVF Cycles (Non-Donor)
8.1.1.1. Market Revenue and Forecast
8.1.2. Thawed IVF Cycles (Non-Donor)
8.1.2.1. Market Revenue and Forecast
8.1.3. Fresh Donor IVF Cycles
8.1.3.1. Market Revenue and Forecast
8.1.4. Thawed Donor IVF Cycles
8.1.4.1. Market Revenue and Forecast
9.1. IVF Services Market, by Procedure
9.1.1. Conventional IVF
9.1.1.1. Market Revenue and Forecast
9.1.2. IVF with ICSI (Intracytoplasmic Sperm Injection)
9.1.2.1. Market Revenue and Forecast
9.1.3. IVF with Donor Eggs
9.1.3.1. Market Revenue and Forecast
9.1.4. Others (PGT, Assisted Hatching)
9.1.4.1. Market Revenue and Forecast
10.1. IVF Services Market, by End-User
10.1.1. Fertility Clinics
10.1.1.1. Market Revenue and Forecast
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast
10.1.3. Surgical Centers
10.1.3.1. Market Revenue and Forecast
10.1.4. Clinical Research Institutes
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Cycle Type
11.1.2. Market Revenue and Forecast, by Procedure
11.1.3. Market Revenue and Forecast, by End-User
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Cycle Type
11.1.4.2. Market Revenue and Forecast, by Procedure
11.1.4.3. Market Revenue and Forecast, by End-User
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Cycle Type
11.1.5.2. Market Revenue and Forecast, by Procedure
11.1.5.3. Market Revenue and Forecast, by End-User
11.2. Europe
11.2.1. Market Revenue and Forecast, by Cycle Type
11.2.2. Market Revenue and Forecast, by Procedure
11.2.3. Market Revenue and Forecast, by End-User
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Cycle Type
11.2.4.2. Market Revenue and Forecast, by Procedure
11.2.4.3. Market Revenue and Forecast, by End-User
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Cycle Type
11.2.5.2. Market Revenue and Forecast, by Procedure
11.2.5.3. Market Revenue and Forecast, by End-User
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Cycle Type
11.2.6.2. Market Revenue and Forecast, by Procedure
11.2.6.3. Market Revenue and Forecast, by End-User
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Cycle Type
11.2.7.2. Market Revenue and Forecast, by Procedure
11.2.7.3. Market Revenue and Forecast, by End-User
11.3. APAC
11.3.1. Market Revenue and Forecast, by Cycle Type
11.3.2. Market Revenue and Forecast, by Procedure
11.3.3. Market Revenue and Forecast, by End-User
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Cycle Type
11.3.4.2. Market Revenue and Forecast, by Procedure
11.3.4.3. Market Revenue and Forecast, by End-User
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Cycle Type
11.3.5.2. Market Revenue and Forecast, by Procedure
11.3.5.3. Market Revenue and Forecast, by End-User
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Cycle Type
11.3.6.2. Market Revenue and Forecast, by Procedure
11.3.6.3. Market Revenue and Forecast, by End-User
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Cycle Type
11.3.7.2. Market Revenue and Forecast, by Procedure
11.3.7.3. Market Revenue and Forecast, by End-User
11.4. MEA
11.4.1. Market Revenue and Forecast, by Cycle Type
11.4.2. Market Revenue and Forecast, by Procedure
11.4.3. Market Revenue and Forecast, by End-User
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Cycle Type
11.4.4.2. Market Revenue and Forecast, by Procedure
11.4.4.3. Market Revenue and Forecast, by End-User
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Cycle Type
11.4.5.2. Market Revenue and Forecast, by Procedure
11.4.5.3. Market Revenue and Forecast, by End-User
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Cycle Type
11.4.6.2. Market Revenue and Forecast, by Procedure
11.4.6.3. Market Revenue and Forecast, by End-User
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Cycle Type
11.4.7.2. Market Revenue and Forecast, by Procedure
11.4.7.3. Market Revenue and Forecast, by End-User
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Cycle Type
11.5.2. Market Revenue and Forecast, by Procedure
11.5.3. Market Revenue and Forecast, by End-User
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Cycle Type
11.5.4.2. Market Revenue and Forecast, by Procedure
11.5.4.3. Market Revenue and Forecast, by End-User
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Cycle Type
11.5.5.2. Market Revenue and Forecast, by Procedure
11.5.5.3. Market Revenue and Forecast, by End-User
12.1. Cook Medical
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Esco Medical
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ferring Pharmaceuticals
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. FUJIFILM Irvine Scientific, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Genea Limited
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Hamilton Thorne Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Indira IVF Hospital Pvt. Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. IVI RMA Global
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Merck KGaA
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Nidacon International AB
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
